Cargando…
Oxaliplatin in practice.
Oxaliplatin, a new third-generation platinum complex, is active in the treatment of colorectal and advanced ovarian cancers, both as monotherapy and in combination therapy. It has demonstrated a very good safety profile, characterized by low haematotoxicity, and moderate and manageable gastrointesti...
Autor principal: | Misset, J. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149889/ https://www.ncbi.nlm.nih.gov/pubmed/9647612 |
Ejemplares similares
-
Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012) -
Ongoing and unsaid on oxaliplatin: the hope.
por: Cvitkovic, E.
Publicado: (1998) -
Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
por: Zhou, Qing-nan, et al.
Publicado: (2023) -
Oxaliplatin-induced Evan's syndrome
por: Earle, C C, et al.
Publicado: (2001) -
Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation
por: Han, Catherine H., et al.
Publicado: (2017)